IDEAS home Printed from https://ideas.repec.org/a/plo/pcbi00/1002959.html
   My bibliography  Save this article

Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model

Author

Listed:
  • Libin Rong
  • Jeremie Guedj
  • Harel Dahari
  • Daniel J Coffield Jr
  • Micha Levi
  • Patrick Smith
  • Alan S Perelson

Abstract

The current paradigm for studying hepatitis C virus (HCV) dynamics in patients utilizes a standard viral dynamic model that keeps track of uninfected (target) cells, infected cells, and virus. The model does not account for the dynamics of intracellular viral replication, which is the major target of direct-acting antiviral agents (DAAs). Here we describe and study a recently developed multiscale age-structured model that explicitly considers the potential effects of DAAs on intracellular viral RNA production, degradation, and secretion as virus into the circulation. We show that when therapy significantly blocks both intracellular viral RNA production and virus secretion, the serum viral load decline has three phases, with slopes reflecting the rate of serum viral clearance, the rate of loss of intracellular viral RNA, and the rate of loss of intracellular replication templates and infected cells, respectively. We also derive analytical approximations of the multiscale model and use one of them to analyze data from patients treated for 14 days with the HCV protease inhibitor danoprevir. Analysis suggests that danoprevir significantly blocks intracellular viral production (with mean effectiveness 99.2%), enhances intracellular viral RNA degradation about 5-fold, and moderately inhibits viral secretion (with mean effectiveness 56%). The multiscale model can be used to study viral dynamics in patients treated with other DAAs and explore their mechanisms of action in treatment of hepatitis C. Author Summary: Chronic infection with hepatitis C virus (HCV) remains an important health-care problem worldwide despite significant progress in the development of HCV therapy since the discovery of the virus in 1989. Current treatment options are focused on direct-acting antiviral agents (DAAs) that target specific steps of the HCV life cycle. Danoprevir, one of the DAAs that inhibit the HCV NS3-4A protease, has induced substantial viral load reductions in patients receiving therapy. We study the viral decline during therapy using a multiscale age-structured model that accounts for the dynamics of intracellular viral replication, and which includes the major steps in the HCV life cycle that are targeted by DAAs. We examine the biological parameters contributing to different phases of the viral decline after treatment initiation. We also explore the mechanisms of action of danoprevir and estimate its treatment effectiveness. The multiscale model provides a theoretical framework for studying virus dynamics in hepatitis C patients treated with other DAAs currently in clinical development, and may help one to optimally combine drugs with complementary modes of action to maximize the HCV cure rate.

Suggested Citation

  • Libin Rong & Jeremie Guedj & Harel Dahari & Daniel J Coffield Jr & Micha Levi & Patrick Smith & Alan S Perelson, 2013. "Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model," PLOS Computational Biology, Public Library of Science, vol. 9(3), pages 1-12, March.
  • Handle: RePEc:plo:pcbi00:1002959
    DOI: 10.1371/journal.pcbi.1002959
    as

    Download full text from publisher

    File URL: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1002959
    Download Restriction: no

    File URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1002959&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pcbi.1002959?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Min Gao & Richard E. Nettles & Makonen Belema & Lawrence B. Snyder & Van N. Nguyen & Robert A. Fridell & Michael H. Serrano-Wu & David R. Langley & Jin-Hua Sun & Donald R. O’Boyle II & Julie A. Lemm &, 2010. "Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect," Nature, Nature, vol. 465(7294), pages 96-100, May.
    2. Narendra M. Dixit & Jennifer E. Layden-Almer & Thomas J. Layden & Alan S. Perelson, 2004. "Modelling how ribavirin improves interferon response rates in hepatitis C virus infection," Nature, Nature, vol. 432(7019), pages 922-924, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alexander Churkin & Danny Barash, 2022. "Mathematical and Computational Biology of Viruses at the Molecular or Cellular Levels," Mathematics, MDPI, vol. 10(23), pages 1-4, November.
    2. Shoya Iwanami & Kosaku Kitagawa & Hirofumi Ohashi & Yusuke Asai & Kaho Shionoya & Wakana Saso & Kazane Nishioka & Hisashi Inaba & Shinji Nakaoka & Takaji Wakita & Odo Diekmann & Shingo Iwami & Koichi , 2020. "Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma," PLOS Biology, Public Library of Science, vol. 18(7), pages 1-17, July.
    3. Alexander Churkin & Stephanie Lewkiewicz & Vladimir Reinharz & Harel Dahari & Danny Barash, 2020. "Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics," Mathematics, MDPI, vol. 8(9), pages 1-30, September.
    4. Markus M. Knodel & Paul Targett-Adams & Alfio Grillo & Eva Herrmann & Gabriel Wittum, 2019. "Advanced Hepatitis C Virus Replication PDE Models within a Realistic Intracellular Geometric Environment," IJERPH, MDPI, vol. 16(3), pages 1-53, February.
    5. Vladimir Reinharz & Alexander Churkin & Harel Dahari & Danny Barash, 2022. "Advances in Parameter Estimation and Learning from Data for Mathematical Models of Hepatitis C Viral Kinetics," Mathematics, MDPI, vol. 10(12), pages 1-13, June.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Dominik Kiemel & Ann-Sophie Helene Kroell & Solène Denolly & Uta Haselmann & Jean-François Bonfanti & Jose Ignacio Andres & Brahma Ghosh & Peggy Geluykens & Suzanne J. F. Kaptein & Lucas Wilken & Piet, 2024. "Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Pranesh Padmanabhan & Narendra M Dixit, 2011. "Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry," PLOS Computational Biology, Public Library of Science, vol. 7(12), pages 1-11, December.
    3. Pranesh Padmanabhan & Narendra M Dixit, 2012. "Viral Kinetics Suggests a Reconciliation of the Disparate Observations of the Modulation of Claudin-1 Expression on Cells Exposed to Hepatitis C Virus," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-7, April.
    4. Pan, Sonjoy & Chakrabarty, Siddhartha P., 2022. "Analysis of a reaction–diffusion HCV model with general cell-to-cell incidence function incorporating B cell activation and cure rate," Mathematics and Computers in Simulation (MATCOM), Elsevier, vol. 193(C), pages 431-450.
    5. Mphatso Kalemera & Dilyana Mincheva & Joe Grove & Christopher J R Illingworth, 2019. "Building a mechanistic mathematical model of hepatitis C virus entry," PLOS Computational Biology, Public Library of Science, vol. 15(3), pages 1-26, March.
    6. Santosh Kumar Sharma & Amar Nath Chatterjee & Bashir Ahmad, 2023. "Effect of Antiviral Therapy for HCV Treatment in the Presence of Hepatocyte Growth Factor," Mathematics, MDPI, vol. 11(3), pages 1-20, February.
    7. Tao Lu & Yangxin Huang & Min Wang & Feng Qian, 2014. "A refined parameter estimating approach for HIV dynamic model," Journal of Applied Statistics, Taylor & Francis Journals, vol. 41(8), pages 1645-1657, August.
    8. Tiffany Benzine & Ryan Brandt & William C Lovell & Daisuke Yamane & Petra Neddermann & Raffaele De Francesco & Stanley M Lemon & Alan S Perelson & Ruian Ke & David R McGivern, 2017. "NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains," PLOS Pathogens, Public Library of Science, vol. 13(6), pages 1-20, June.
    9. Luo, Yantao & Zhang, Long & Zheng, Tingting & Teng, Zhidong, 2019. "Analysis of a diffusive virus infection model with humoral immunity, cell-to-cell transmission and nonlinear incidence," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 535(C).
    10. Sonjoy Pan & Siddhartha P. Chakrabarty, 2020. "Hopf Bifurcation and Stability Switches Induced by Humoral Immune Delay in Hepatitis C," Indian Journal of Pure and Applied Mathematics, Springer, vol. 51(4), pages 1673-1695, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pcbi00:1002959. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ploscompbiol (email available below). General contact details of provider: https://journals.plos.org/ploscompbiol/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.